Shares of Neoleukin Therapeutics spike after announcing layoffs and potential sale or merger Neoleukin Therapeutics is slashing its workforce by about 70% as it seeks “strategic alternatives” for its future, according to a… Read More
New Seattle startup emerges from UW to develop cancer-fighting protein three decades in the making For 30 years, scientists have been trying to unleash the promise of Interleukin-2 (IL-2), a powerful protein that fights cancer… Read More
